WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer

被引:31
|
作者
Kawasaki, Takako [1 ,2 ]
Ohnishi, Mutsuko [2 ]
Suemoto, Yuko [2 ]
Kirkner, Gregory J. [1 ,3 ]
Liu, Zhiqian [2 ]
Yamamoto, Hiroyuki [4 ]
Loda, Massimo [1 ,2 ]
Fuchs, Charles S. [1 ,2 ,3 ]
Ogino, Shuji [1 ,2 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA USA
[4] Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan
关键词
colon cancer; WRN; mucin; DNA methylation; CIMP; MSI;
D O I
10.1038/modpathol.3800996
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Werner syndrome is a premature aging syndrome characterized by early onset of cancer and abnormal cellular metabolism of glycosaminoglycan. The WRN helicase plays an important role in the maintenance of telomere function. WRN promoter methylation and gene silencing are common in colorectal cancer with the CpG island methylator phenotype (CIMP), which is associated with microsatellite instability (MSI) and mucinous tumors. However, no study has examined the relationship between mucinous differentiation, WRN methylation, CIMP and MSI in colorectal cancer. Utilizing 903 population-based colorectal cancers and real-time PCR (MethyLight), we quantified DNA methylation in WRN and eight other promoters (CACNA1G, CDKN2A, CRABP1, IGF2, MLH1, NEUROG1, RUNX3 and SOCS1) known to be specific for CIMP. Supporting WRN as a good CIMP marker, WRN methylation was correlated well with CIMP-high diagnosis (>= 6/8 methylated promoters), demonstrating 89% sensitivity and 81% specificity. WRN methylation was associated with the presence of any mucinous component and >= 50% mucinous component (P<0.0001). Because both MSI and CIMP were associated with mucinous tumors and WRN methylation, we stratified tumors into 9 MSI/CIMP subtypes, to examine whether the relationship between WRN methylation and mucin still persisted. In each MSI/CIMP subtype, tumors with mucinous component were persistently more common in WRN-methylated tumors than WRN-unmethylated tumors (P=0.004). No relations of WRN methylation with other variables (age, sex, tumor location, poor differentiation, signet ring cells, lymphocytic reactions, KRAS, BRAF, p53, p21 or 18q loss of heterozygosity) persisted after tumors were stratified by CIMP status. In conclusion, WRN methylation is associated with mucinous differentiation independent of CIMP and MSI status. Our data suggest a possible role of WRN methylation in mucinous differentiation, and may provide explanation to the enigmatic association between mucin and MSI/CIMP.
引用
收藏
页码:150 / 158
页数:9
相关论文
共 50 条
  • [41] Aberrant TET1 methylation closely associated with CpG island methylator phenotype in colorectal cancer
    Ichimura, Norihisa
    Shinjo, Keiko
    Ohka, Fumiharu
    Katsushima, Keisuke
    Hatanaka, Akira
    Tojo, Masayuki
    Shimizu, Yasuhiro
    Yamamoto, Eiichiro
    Suzuki, Hiromu
    Kondo, Yutaka
    [J]. CANCER RESEARCH, 2015, 75
  • [42] Do histopathologic features of colorectal carcinoma predict microsatellite instability (MSI) or CpG island methylator phenotype (CIMP) or both?
    Ogino, S.
    Loda, M.
    Fuchs, C. S.
    [J]. MODERN PATHOLOGY, 2007, 20 : 126A - 126A
  • [43] Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
    Advani, Shailesh Mahesh
    Advani, Pragati Shailesh
    Brown, Derek W.
    DeSantis, Stacia M.
    Korphaisarn, Krittiya
    VonVille, Helena M.
    Bressler, Jan
    Lopez, David S.
    Davis, Jennifer S.
    Daniel, Carrie R.
    Sarshekeh, Amir Mehrvarz
    Braithwaite, Dejana
    Swartz, Michael D.
    Kopetz, Scott
    [J]. BMC CANCER, 2019, 19 (01)
  • [44] CPG ISLAND METHYLATOR PHENOTYPE AND MICROSATELLITE INSTABILITY AS A PROGNOSTIC FACTOR IN COLON CANCER TREATED WITH ADJUVANT FOLFOX CHEMOTHERAPY
    Lee, H. J.
    Han, S.
    Bae, J. M.
    Oh, D.
    Im, S.
    Park, K. J.
    Bang, Y.
    Park, J. G.
    Kang, G. H.
    Kim, T.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 208 - 208
  • [45] Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae, Jeong Mo
    Rhee, Ye-Young
    Kim, Kyung Ju
    Wen, Xianyu
    Song, Young Seok
    Cho, Nam-Yun
    Kim, Jung Ho
    Kang, Gyeong Hoon
    [J]. HUMAN PATHOLOGY, 2016, 47 (01) : 85 - 94
  • [46] Preference of aberrant methylation of promoter region in multiple genes indicates presence of Cpg island methylator phenotype in colorectal cancers
    Hokazono, Koji
    Ueki, Takashi
    Konomi, Hiroyuki
    Mibu, Ryuichi
    Tanaka, Masao
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A320 - A321
  • [47] Phenotype of microsatellite-stable colorectal carcinomas with CpG island methylation
    Chirieac, LR
    Shen, LL
    Catalano, PJ
    Issa, JP
    Hamilton, SR
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (04) : 429 - 436
  • [48] Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)
    Chang, Shih-Ching
    Li, Anna Fen-Yau
    Lin, Pei-Ching
    Lin, Chun-Chi
    Lin, Hung-Hsin
    Huang, Shen-Chieh
    Lin, Chien-Hsing
    Liang, Wen-Yi
    Chen, Wei-Shone
    Jiang, Jeng-Kai
    Lin, Jen-Kou
    Yang, Shung-Haur
    Lan, Yuan-Tzu
    [J]. CANCERS, 2020, 12 (11) : 1 - 16
  • [49] Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer
    Ogino, Shuji
    Kawasaki, Takako
    Kirkner, Gregory J.
    Suemoto, Yuko
    Meyerhardt, Jeffrey A.
    Fuchs, Charles S.
    [J]. GUT, 2007, 56 (11) : 1564 - 1571
  • [50] Sirtuin 1 Polymorphisms, Energy Balance-related Factors, and Risk of Colorectal Cancer by Microsatellite Instability and CpG Island Methylator Phenotype Status
    Hrzic, R.
    Simons, C. C. J.
    Schouten, L. J.
    van Engeland, M.
    van den Brandt, P. A.
    Weijenberg, M. P.
    [J]. JOURNAL OF PATHOLOGY, 2018, 246 : S31 - S31